References
- Buncan G G, Joiner C L, Lee C T. Sulfonylurea symposium: Methods of selection of diabetic patients sensitive to sulfonylurea compounds. Metabolism 1956; 5: 964–71
- Friedlander O E. Use of tolbutamide in insulin-resistant diabetes. Report of a case. N Engl J Med 1957; 257: 11–4
- Peacock I, Tattersall R B. The difficult choice of treatment for poorly controlled maturity-onset diabetes: Tablets or insulin. Br Med J 1984; 288: 1956–9
- Lebovitz H E. Update of oral hypoglycemic agents. World book of diabetes in practice, L P Krall. Elsevier Science Publishers BV, Amsterdam 1986; 72–5, Vol 2
- Rizza R A. Combined sulfonylurea and insulin therapy in insulin-dependent diabetes: Research or practice. Diabetes Care 1985; 8: 511–4
- Falko J M, Osei K. Combination insulin/glyburide therapyu in Type II diabetes mellitus. Effects on lipoprotein metabolism and glucoregulation. Am J Med 1985; 79(3B)92–101
- Groop L, Harno K, Nikkilä E A, Pelkonen R, Tolppa-Nen E M. Transient effect of the combination of insulin and sulfonylurea (glibenclamide) on glycemic control in non-insulin-dependent diabetics poorly controlled with insulin alone. Acta Med Scand 1985; 217: 33–9
- Longnecker M P, Elsenhans V D, Leiman S M, Owen O E, Boden G. Insulin and a sulfonylurea agent in non-insulin-dependent diabetes mellitus. Arch Intern Med 1986; 146: 673–6
- Lins P E, Lundblad S, Persson-Trotzig E, Adamson U. Glibenclamide improves the response to insulin treatment in non-insulin-dependent diabetics with second failure to sulfonylurea therapy. Acta Med Scand 1988; 223: 171–9
- Stenman S, Groop P H, Saloranta C, Tötterman K J, Fyhrqvist F, Groop L. Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-de-pendent) diabetic patients with secondary failure to oral hypoglycemic agents. Diabetologia 1988; 31: 206–13
- Casner P R. Insulin-glyburide combination therapy for non-insulin-dependent diabetes mellitus: a long-term, double-blind, placebo-controlled trial. Clin Pharmacol Ther 1988; 44: 594–603
- Schade D S, Mitchell W J, Griego G. Addition of sulfonylurea to insulin treatment in poorly controlled Type II diabetes. A double-blind, randomized clnical trial. JAMA 1987; 2441–5
- Kyllästinen M, Groop L. Combination of insulin and glibenclamide in the treatment of elderly non-insulin dependent (type 2) diabetic patients. Ann Clin Res 1985; 17: 100–4
- Lewitt M S, Yu V KF, Rennie G C, et al. Effects of combined insulin-sulfonylurea therapy in Type 2 patients. Diabetes Care 1989; 12: 379–83
- Gutniak M, Karlander S G, Efendic S. Glyburide decreases insulin requirement, increases B-cell response to mixed meal, and does not affect insulin sensitivity: Effect of short- and long-term combined treatment in secondary failure to sulfonylurea. Diabetes Care 1987; 545–54
- Lebovitz H E. Oral hypoglycemic agents. The diabetes annual, 3, K GMM Alberti, L P Krall. Elsevier Science Publishers BV, Amsterdam 1987; 72–93
- Osei K, O'Dorisio T, Falko J M. Concomitant insulin and sulfonylurea therapy in patients with type II diabetes. Am J Med 1984; 77: 1002–9
- Rosenqvist U, Luft R. Diabetes care in the community. The diabetes annual, 4, K GMM Alberti, L P Krall. Elsevier Science Publishers BV, Amsterdam 1988; 162–77
- Jeppson J O, Franzen B, Nilsson K O. Determination of glycosylated hemoglobin fraction HbAlc in diabetes mellitus by thin-layer electro-focusing. Science Tools 1978; 25: 69–72
- DeFronzo R A, Ferranninni E. The pathogenesis of non-insulin-dependent diabetes. Medicine 1982; 61: 125–40